Evidence map›Paper›PMID 38026170›Full record

ReviewiScience2023

Engineered Extracellular Vesicles: A potential treatment for regeneration.

Wen Cheng, Chenyu Xu, Yuran Su, Youqing Shen, Qiang Yang, Yanmei Zhao, Yanhong Zhao, Yue Liu

Abstract readReview
In one paragraph

Review in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Integrative Approaches to Treating Cellular Senescence in Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Therapeutic Exosomes CarryingBiomedicines · 2026
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wen ChengDepartment of Orthodontics, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China.
Chenyu XuDepartment of Orthodontics, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China.
Yuran SuDepartment of Orthodontics, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China.
Youqing ShenDepartment of Orthodontics, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China.
Qiang YangDepartment of Orthopedics, Tianjin University Tianjin Hospital, Tianjin University, Tianjin 300211, China.
Yanmei ZhaoInstitute of Disaster and Emergency Medicine, Tianjin University, Tianjin 300072, China.
Yanhong ZhaoDepartment of Orthodontics, School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China.
Yue LiuDepartment of Orthopedics, Tianjin University Tianjin Hospital, Tianjin University, Tianjin 300211, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) play a critical role in various physiological and pathological processes. EVs have gained recognition in regenerative medicine due to their biocompatibility and low immunogenicity. However, the practical application of EVs faces challenges such as limited targeting ability, low yield, and inadequate therapeutic effects. To overcome these limitations, engineered EVs have emerged. This review aims to comprehensively analyze the engineering methods utilized for modifying donor cells and EVs, with a focus on comparing the therapeutic potential between engineered and natural EVs. Additionally, it aims to investigate the specific cell effects that play a crucial role in promoting repair and regeneration, while also exploring the underlying mechanisms involved in the field of regenerative medicine.

Indexed as

BioengineeringBiological sciencesCell biology

Identifiers

PMID38026170
PMCPMC10651684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.